Viveve Medical, Inc. (VIVE): Price and Financial Metrics

Viveve Medical, Inc. (VIVE)

Today's Latest Price: $0.56 USD

0.01 (-1.77%)

Updated Nov 27 1:00pm

Add VIVE to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

VIVE Stock Summary

  • VIVE has a market capitalization of $12,039,503 -- more than approximately only 5.04% of US stocks.
  • With a year-over-year growth in debt of -81.95%, Viveve Medical Inc's debt growth rate surpasses only 2.84% of about US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for VIVE comes in at -165.51% -- higher than that of only 2.1% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Viveve Medical Inc, a group of peers worth examining would be KALA, FLDM, CTSO, TWOU, and MBII.
  • VIVE's SEC filings can be seen here. And to visit Viveve Medical Inc's official web site, go to

VIVE Stock Price Chart Interactive Chart >

Price chart for VIVE

VIVE Price/Volume Stats

Current price $0.56 52-week high $2.09
Prev. close $0.57 52-week low $0.42
Day low $0.54 Volume 638,600
Day high $0.57 Avg. volume 2,556,671
50-day MA $0.52 Dividend yield N/A
200-day MA $0.64 Market Cap 12.05M

Viveve Medical, Inc. (VIVE) Company Bio

Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal laxity. The company was founded in 2005 and is based in Sunnyvale, California.

VIVE Latest News Stream

Event/Time News Detail
Loading, please wait...

VIVE Latest Social Stream

Loading social stream, please wait...

View Full VIVE Social Stream

Latest VIVE News From Around the Web

Below are the latest news stories about Viveve Medical Inc that investors may wish to consider to help them evaluate VIVE as an investment opportunity.

The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Akouos Inc (NASDAQ: AKUS ) Albireo Pharma Inc (NASDAQ: ALB )(announced positive Phase 3 results for odevixibat in a liver disorder called progressive familial intrahepatic cholestasis) Castle Biosciences Inc (NASDAQ: CSTL ) Harmony Biosciences Holdings Inc (NASDAQ: HRMY ) Kura Oncology Inc (NASDAQ: KURA ) Merit Medical Systems, Inc. (NASDAQ: MMSI )(announced sale of manufacturing equipment and associated assets used in its hypotube manufacturing business) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 8) ADiTx Therapeutics Inc (NASDAQ: ADTX ) AEterna Zentaris Inc. (NASDAQ: AEZS )(announced the presentation of data from pediatric study of macimorelin for childhood-o...

Benzinga | September 9, 2020

Viveve Medical up big on revival of RF treatment for urinary incontinence

Nano cap Viveve Medical (VIVE) rockets 75% premarket on robust volume in reaction to its announcement of positive results from a 36-subject three-arm feasibility study evaluating its Cryogen-cooled Monopolar Radiofrequency ((CMRF)) for the treatment of mild-to-moderate stress urinary incontinence ((SUI)) in women.The primary endpoint was the change from baseline in the standardized...

Seeking Alpha | August 25, 2020

SWBI, ONVO, YRCW and PTI among midday movers

Gainers: Viveve Medical (VIVE) +111%.VivoPower International (VVPR) +57%.Sigma Labs (SGLB) +27%.FTS International (FTSI) +25%.BigCommerce (BIGC) +24%.Phoenix Tree (DNK) +24%.Cutera (CUTR) +18%.Jiayin (JFIN) +18%.Organovo (ONVO) +18%.Orchard Therapeutics (ORTX) +17%.Losers: Sonnet BioTherapeutics (SONN) -19%.Anixa Biosciences (ANIX) -19%.YRC Worldwide (YRCW) -18%.Children's Place (PLCE) -17%.Lipocine (LPCN) -16%.Velocity Financial (VEL) -16%.ATIF Holdings (ATIF) -15%.Proteostasis Therapeutics (PTI) -14%.Liminal BioSciences (LMNL) -13%.Kirkland's (KIRK) -12%....

Seeking Alpha | August 25, 2020

The Daily Biotech Pulse: Altimmune Reports Positive Preclinical Data For Intranasal COVID-19 Vaccine, AbbVie Licenses Morphic's Drug, Viveve Clinical Readout

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Abbott Laboratories (NYSE: ABT ) Cancer Genetics Inc (NASDAQ: CGIX ) (announced a deal to buy organoid start up company StemoniX) Cardiff Oncology Inc (NASDAQ: CRDF ) Catabasis Pharmaceuticals Inc (NASDAQ: CATB ) Cerus Corporation (NASDAQ: CERS ) (moved on FDA's emergency use authorization for plasma therapy as a potential COVID-19 treatment) ESSA Pharma Inc (NASDAQ: EPIX ) Fortress Biotech (NASDAQ: FBIO ) Inozyme Pharma Inc (NASDAQ: INZY ) Kamada Ltd. (NASDAQ: KMD) (reacted to the news of EUA for plasma anti-COVID-19 therapy) Keros Therapeutics Inc (NASDAQ: KROS ) Lantern Pharma Inc. (NASDAQ: LTRN ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Pacific Biosciences of California Inc (NASDAQ: PACB ) Principia Biopharma Inc (NASDA...

Benzinga | August 25, 2020

Viveve Announces Clearance of Viveve 2.0 System in Thailand

ENGLEWOOD, CO / ACCESSWIRE / July 14, 2020 / Viveve Medical, Inc. (VIVE), a medical technology company focused on women's intimate health, today announced it has received regulatory clearance from the Thai Food and Drug Administration for the company's next-generation Viveve 2.0 Cryogen-cooled Monopolar Radiofrequency (CMRF) system and consumable treatment tips. Thailand is one of the leading women's health and aesthetic medicine markets in Southeast Asia and an important addition to Viveve's expanding global commercial distribution network.

Yahoo | July 14, 2020

Read More 'VIVE' Stories Here

VIVE Price Returns

1-mo 25.84%
3-mo -8.57%
6-mo -10.96%
1-year -33.66%
3-year -99.89%
5-year N/A
YTD -55.56%
2019 -98.80%
2018 -78.87%
2017 -3.50%
2016 N/A
2015 N/A

Continue Researching VIVE

Want to see what other sources are saying about Viveve Medical Inc's financials and stock price? Try the links below:

Viveve Medical Inc (VIVE) Stock Price | Nasdaq
Viveve Medical Inc (VIVE) Stock Quote, History and News - Yahoo Finance
Viveve Medical Inc (VIVE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7401 seconds.